Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7838]

Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumour progression

Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumour progression

Innovative immunotherapy shows promise in early clinical trial for breast cancer

Innovative immunotherapy shows promise in early clinical trial for breast cancer

Experts warn cervical cancer will not be eliminated unless expertise of advocacy groups and the needs of women are reflected in screening strategies

Experts warn cervical cancer will not be eliminated unless expertise of advocacy groups and the needs of women are...

B7-H4 as a therapeutic target in adenoid cystic carcinoma

B7-H4 as a therapeutic target in adenoid cystic carcinoma

Bioinspired micro- and nanostructured systems for cancer therapy

Bioinspired micro- and nanostructured systems for cancer therapy

New survey finds that prior authorisation delays lead to serious harm for people with cancer

New survey finds that prior authorisation delays lead to serious harm for people with cancer

More cancers are being treated with personalised therapies before surgery

More cancers are being treated with personalised therapies before surgery

Institute researchers design novel immunotherapy for brain cancer

Institute researchers design novel immunotherapy for brain cancer

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

European Commission approves tislelizumab for first-line treatment of advanced/metastatic oesophageal squamous cell carcinoma and gastric or gastroesophageal junction cancer

European Commission approves tislelizumab for first-line treatment of advanced/metastatic oesophageal squamous...

More from ecancer